Campbell & CO Investment Adviser LLC trimmed its holdings in Inovalon Holdings Inc (NASDAQ:INOV) by 29.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,892 shares of the technology company’s stock after selling 6,112 shares during the quarter. Campbell & CO Investment Adviser LLC’s holdings in Inovalon were worth $394,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also made changes to their positions in the company. Redwood Investments LLC acquired a new position in Inovalon during the 2nd quarter worth approximately $19,245,000. Invesco Ltd. raised its stake in Inovalon by 1,098.4% during the 1st quarter. Invesco Ltd. now owns 629,311 shares of the technology company’s stock worth $10,484,000 after buying an additional 576,799 shares during the period. Spence Asset Management acquired a new position in Inovalon during the 3rd quarter worth approximately $9,969,000. Nordea Investment Management AB raised its stake in Inovalon by 99.9% during the 2nd quarter. Nordea Investment Management AB now owns 618,572 shares of the technology company’s stock worth $11,480,000 after buying an additional 309,120 shares during the period. Finally, Goldman Sachs Group Inc. raised its stake in Inovalon by 52.9% during the 2nd quarter. Goldman Sachs Group Inc. now owns 572,468 shares of the technology company’s stock worth $11,026,000 after buying an additional 198,178 shares during the period. 33.44% of the stock is currently owned by institutional investors.
In other Inovalon news, insider Jason Capitel sold 20,000 shares of the stock in a transaction on Wednesday, August 5th. The stock was sold at an average price of $25.18, for a total transaction of $503,600.00. Following the completion of the transaction, the insider now directly owns 576,504 shares of the company’s stock, valued at $14,516,370.72. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Jonathan R. Boldt sold 5,334 shares of the stock in a transaction on Tuesday, October 13th. The shares were sold at an average price of $27.16, for a total value of $144,871.44. Following the transaction, the chief financial officer now directly owns 253,029 shares of the company’s stock, valued at $6,872,267.64. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 39,336 shares of company stock valued at $1,006,806. 49.59% of the stock is currently owned by corporate insiders.
INOV stock opened at $27.08 on Friday. The firm has a market cap of $4.21 billion, a PE ratio of 386.86, a P/E/G ratio of 3.34 and a beta of 0.70. The company has a quick ratio of 1.88, a current ratio of 1.88 and a debt-to-equity ratio of 1.35. The business has a 50 day moving average of $25.61 and a 200-day moving average of $20.92. Inovalon Holdings Inc has a 12-month low of $13.39 and a 12-month high of $27.93.
Inovalon (NASDAQ:INOV) last released its earnings results on Wednesday, July 29th. The technology company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.04. The company had revenue of $162.20 million during the quarter, compared to analyst estimates of $159.46 million. Inovalon had a return on equity of 9.09% and a net margin of 1.75%. Inovalon’s quarterly revenue was up 3.3% on a year-over-year basis. During the same period in the prior year, the company posted $0.13 earnings per share. On average, research analysts expect that Inovalon Holdings Inc will post 0.46 earnings per share for the current year.
Inovalon Company Profile
Inovalon Holdings, Inc, a technology company, provides cloud-based platforms empowering data-driven healthcare. It operates the Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights.
Recommended Story: How Investors Use a Balance Sheet
Receive News & Ratings for Inovalon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon and related companies with MarketBeat.com's FREE daily email newsletter.